NCT05980884View on ClinicalTrials.gov

Using Gut Microbial Gbu Gene Testing to Estimate Host TMAO Production Capacity

NARecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

April 25, 2026

Study Completion Date

July 30, 2026

Conditions
Gut Dysbiosis for TMAO Production From L-carnitine Consumption
Interventions
DIETARY_SUPPLEMENT

L-carnitine

Participants are required to take a capsule containing 500mg L-carnitine/day continuous for 7-10 days.

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER